Trial NCT01806064

View at ClinicalTrials.gov 
Org. Study IDs: 105RC101

Last trial update was posted on 2020-10-19

MeSH Interventions

Axitinib

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Renal Cell Carcinoma

Stopping Reasons

The study did not meet endpoint.

Limitations And Caveats

The study was terminated early due to lack of efficacy therefore protein biomarkers (P1b and P2), PK (P2), immunogenicity (P2) and disease control rate at 16 weeks by RECIST 1.1 and Choi criteria were not analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID